Skip to Content
 
Center for International Blood and Marrow Transplant Research

GS18-01a

Main Content

Outcomes after HLA-haploidentical donor vs matched unrelated donor transplantation in the setting of post-transplant cyclophosphamide

Study #: GS18-01a

Study Status: Published

Presentation(s)

2020, ASH (Oral)

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.

Citation

Gooptu M, Romee R, St Martin A, Arora M, Al Malki M, Antin JH, Bredeson CN, Brunstein CG, Chhabra S, Fuchs EJ, Ghosh N, Grunwald MR, Kanakry CG, Kekre N, McGuirk JP, McNiece IK, Mehta RS, Mielcarek M, Milano F, Modi D, Reshef R, Solomon SR, Schroeder MA, Waller EK, Inamoto Y, Soiffer RJ, Eapen M.

Blood. 2021, Jul 22: 138(3): 138(3):273-282. doi: 10.1182/blood.2021011281. Epub 2021, Apr 13. PMCID:PMC8310426.

PubMed

PMID: 34292325

Abstract